Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Blue Sky Uranium Expands Drill Plan to Advance the Ivana Uranium-Vanadium Project (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News UNITY Biotechnology Inc UBX

Healthcare Biotechnology
UNITY Biotechnology, Inc. is a biotechnology company engaged in researching and developing therapeutics to slow, halt or reverse diseases of aging. The Company is focused on creating medicines to selectively eliminate or modulate senescent cells and thereby provide transformative benefit in age-related ophthalmologic and neurologic diseases. It is targeting specific biological mechanisms... see more

Recent & Breaking News (NDAQ:UBX)

UNITY Biotechnology Announces $80M Debt Financing From Hercules Capital

GlobeNewswire August 4, 2020

UNITY Biotechnology, Inc. Reports Second Quarter 2020 Financial Results and Clinical Program Updates

GlobeNewswire July 31, 2020

UPDATE - UNITY Biotechnology, Inc. to Announce Second Quarter 2020 Financial Results

GlobeNewswire July 29, 2020

UNITY Biotechnology, Inc. to Announce Second Quarter 2020 Financial Results

GlobeNewswire July 24, 2020

UNITY Biotechnology Announces CFO Transition

GlobeNewswire July 6, 2020

UNITY Biotechnology, Inc. Provides Updates on Lead Development Programs

GlobeNewswire July 1, 2020

UNITY Biotechnology to Participate in Fireside Chat at the Goldman Sachs 41st Annual Global Healthcare Conference

GlobeNewswire June 11, 2020

UNITY Biotechnology to Participate in the Goldman Sachs 41st Annual Global Healthcare Conference

GlobeNewswire May 28, 2020

UNITY Biotechnology, Inc. Reports First Quarter 2020 Financial Results and Business Updates

GlobeNewswire May 7, 2020

UNITY Biotechnology, Inc. to Announce First Quarter 2020 Financial Results

GlobeNewswire May 4, 2020

UNITY Biotechnology Completes Enrollment in Phase 1b Study of UBX0101

GlobeNewswire March 31, 2020

UNITY Biotechnology Announces Start of New CEO and New Employment Inducement Grants

GlobeNewswire March 30, 2020

UNITY Biotechnology, Inc. Reports Fourth Quarter and Full Year 2019 Financial Results

GlobeNewswire March 11, 2020

UNITY Biotechnology, Inc. to Announce Fourth Quarter and Full Year 2019 Financial Results

GlobeNewswire March 3, 2020

UNITY Biotechnology Appoints Anirvan Ghosh, Ph.D. as Chief Executive Officer

GlobeNewswire March 2, 2020

UNITY Biotechnology Provides Pipeline and Business Updates

GlobeNewswire February 25, 2020

UNITY Biotechnology, Inc. to Participate in the Cowen and Company 40th Annual Health Care Conference

GlobeNewswire February 24, 2020

UNITY Biotechnology, Inc. Announces First Patient Dosed in Phase 2 Study of UBX0101 in Osteoarthritis of the Knee

GlobeNewswire October 31, 2019

UNITY Biotechnology, Inc. Announces Upcoming Scientific Presentations at ACR 2019 Annual Meeting

GlobeNewswire October 24, 2019

Unity Biotechnology, Inc. to Announce Third Quarter 2019 Financial Results

GlobeNewswire October 23, 2019